Skip to content
Disclosery

VHCP Management, LLC

Follow

13F filer, CIK 1479355, NEW YORK, NY

VHCP Management, LLC reported $165,452,000 across 21 holdings for the quarter ended 2015-12-31, in a 13F-HR filed 2016-02-12. Its ten largest share positions make up 89.08% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-16-014511

Period
2015-12-31
Reported value
$165M
Holdings
21
Top 10 weight
89.08%
New
3
Sold out
0

Largest buys vs the previous quarter

SecurityShares changeApprox. value
GLOBAL BLOOD THERAPEUTICS U…new+60,691$1.96M
EDGE THERAPEUTICS INCnew+135,000$1.69M
CTMXnew+75,000$1.56M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
ANACOR PHARMACEUTICALS INCreduced-1,037,718-$117M
RGNXreduced-1,030,954-$17.1M
DBV Technologiesreduced-230,167-$16.1M
ASNDreduced-721,152-$13.2M
Alcobra Ltdreduced-1,015,500-$6.38M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2015

Share positions as resolved from 13F-HR 0000950123-16-014511, largest first. % of portfolio is the value over $165,452,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
DBV TechnologiesDBV TechnologiesQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 693,810 shares; 2015Q2: 693,810 shares; 2015Q3: 693,810 shares; 2015Q4: 463,643 shares 463,643$32.5M19.65%-230,167
HRTXHERON THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 1,095,734 shares; 2015Q2: 1,095,734 shares; 2015Q3: 1,095,734 shares; 2015Q4: 1,095,734 shares 1,095,734$29.3M17.68%0Timeline
GW PHARMACEUTICALS PLCGW PHARMACEUTICALS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 311,853 shares; 2015Q2: 311,853 shares; 2015Q3: 311,853 shares; 2015Q4: 311,853 shares 311,853$21.7M13.09%0
ANACOR PHARMACEUTICALS INCANACOR PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 1,178,474 shares; 2015Q2: 1,178,474 shares; 2015Q3: 1,178,474 shares; 2015Q4: 140,756 shares 140,756$15.9M9.61%-1,037,718
CHRSCOHERUS ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 870,269 shares; 2015Q2: 870,269 shares; 2015Q3: 870,269 shares; 2015Q4: 611,010 shares 611,010$14M8.48%-259,259Timeline
LIPOCINE INC NEWLIPOCINE INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 669,921 shares; 2015Q2: 1,269,921 shares; 2015Q3: 1,269,921 shares; 2015Q4: 849,921 shares 849,921$11M6.64%-420,000
AVALANCHE BIOTAVALANCHE BIOTQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 1,382,735 shares; 2015Q2: 1,382,735 shares; 2015Q3: 1,382,735 shares; 2015Q4: 1,102,735 shares 1,102,735$10.5M6.35%-280,000
FLAMEL TECHNOLOGIES-SP ADRFLAMEL TECHNOLOGIES-SP ADRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 500,000 shares; 2015Q2: 500,000 shares; 2015Q3: 500,000 shares; 2015Q4: 500,000 shares 500,000$6.11M3.69%0
ZAFGEN INCZAFGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 541,480 shares; 2015Q2: 541,480 shares; 2015Q3: 541,480 shares; 2015Q4: 541,480 shares 541,480$3.41M2.06%0
Alcobra LtdAlcobra LtdQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 1,500,000 shares; 2015Q2: 1,500,000 shares; 2015Q3: 1,500,000 shares; 2015Q4: 484,500 shares 484,500$3.04M1.84%-1,015,500
AKARI THERAPEUTICS PLCAKARI THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: 527,842 shares; 2015Q4: 158,352 shares 158,352$2.3M1.39%-369,490
OCERA THERAPEUTICS INC COMOCERA THERAPEUTICS INC COMQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 703,730 shares; 2015Q2: 703,730 shares; 2015Q3: 703,730 shares; 2015Q4: 703,730 shares 703,730$2.2M1.33%0
ARCA biopharma IncARCA biopharma IncQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: not reported; 2015Q2: 10,789,324 shares; 2015Q3: 1,541,331 shares; 2015Q4: 462,399 shares 462,399$2.15M1.3%-1,078,932
GLOBAL BLOOD THERAPEUTICS U…GLOBAL BLOOD THERAPEUTICS USDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: not reported; 2015Q4: 60,691 shares 60,691$1.96M1.19%new
Cynapsus Therapeutics IncCynapsus Therapeutics IncQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 5,878,855 shares; 2015Q2: 367,427 shares; 2015Q3: 367,427 shares; 2015Q4: 110,226 shares 110,226$1.7M1.03%-257,201
EDGE THERAPEUTICS INCEDGE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: not reported; 2015Q4: 135,000 shares 135,000$1.69M1.02%new
ASNDASCENDIS PHARMA A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 811,152 shares; 2015Q2: 811,152 shares; 2015Q3: 811,152 shares; 2015Q4: 90,000 shares 90,000$1.65M1%-721,152Timeline
CTMXCYTOMX THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: not reported; 2015Q4: 75,000 shares 75,000$1.56M0.95%newTimeline
Sierra Oncology, Inc.Sierra Oncology, Inc.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: 250,000 shares; 2015Q4: 75,000 shares 75,000$1.13M0.68%-175,000
RGNXREGENXBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: 1,083,454 shares; 2015Q4: 52,500 shares 52,500$872K0.53%-1,030,954Timeline
STEMLINE THERAPEUTICS INCSTEMLINE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 451,400 shares; 2015Q2: 451,400 shares; 2015Q3: 451,400 shares; 2015Q4: 135,420 shares 135,420$855K0.52%-315,980

How Q4 2015 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000950123-16-014511 base2016-02-12acceptance time not in the bulk data set